11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6568/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :29/07/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : NOVEL PHARMACEUTICALS<br />

(51) International classification :C07D 471/04 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :60/774,580<br />

1)PFIZER LIMITED<br />

(32) Priority Date :17/02/2006<br />

Address <strong>of</strong> Applicant :RAMSGATE ROAD, SANDWICH<br />

(33) Name <strong>of</strong> priority country :U.S.A.<br />

KENT, CT13 9NJ, UNITED KINGDOM. U.K.<br />

(86) International Application No :PCT/IB2007/000368 (72)Name <strong>of</strong> Inventor :<br />

Filing Date<br />

:05/02/2007<br />

1)PETER JONES<br />

(87) International Publication No :WO 2007/093901 2)DAVID CAMERON PRYDE<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

3)THIEN DUC TRAN<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present invention relates to immune response modifiers <strong>of</strong> Formula (I), which act selectively through agonism, <strong>of</strong> Toll-Like<br />

Receptors (TLRs), uses there<strong>of</strong>, processes for the preparation there<strong>of</strong>, intermediates used in the preparation there<strong>of</strong> <strong>and</strong> compositions<br />

containing said inhibitors. These inhibitors have utility in a variety <strong>of</strong> therapeutic areas including the treatment <strong>of</strong> infectious disease<br />

such as Hepatitis (e.g. HCV, HBV), genetically related viral infection <strong>and</strong> cancer.<br />

No. <strong>of</strong> Pages : 153 No. <strong>of</strong> Claims : 38<br />

The Patent Office Journal 24/10/2008 26024

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!